Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03024437
Title Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roberto Pili
Indications

renal cell carcinoma

Therapies

Atezolizumab + Entinostat

Atezolizumab + Bevacizumab + Entinostat

Atezolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.